Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Bortezomib/dexamethasone2件: Bortezomib,
Dexamethasone		2件: D00292 (Name: Dexamethasone),
D03150 		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 283
2Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone2件: Bortezomib,
Dexamethasone		2件: D00292 (Name: Dexamethasone),
D03150 		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28
3Bupivacaine/epinephrine/dexamethasone3件: Bupivacaine (Synonym: ReadySharp Anesthetics plus Dexamethasone),
Dexamethasone,
Epinephrine		3件: D00095 ,
D00292 (Name: Dexamethasone),
D07552 		15件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
NR3C1,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 96
4Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine3件: Azathioprine,
Dexamethasone,
Rituximab		3件: D00238 ,
D00292 (Name: Dexamethasone),
D02994 		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 35
5Control intervention (no dexamethasone)1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
6Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)7件: Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone		6件: D00088 ,
D00292 (Name: Dexamethasone),
D00472 ,
D00473 ,
D00973 ,
D07749 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
7Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		4件: D00287 ,
D00292 (Name: Dexamethasone),
D03150 ,
D07760 		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28
8Cyclophosphamide, Bortezomib, dexamethasone3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		4件: D00287 ,
D00292 (Name: Dexamethasone),
D03150 ,
D07760 		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28
9Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab4件: Bortezomib,
Cyclophosphamide,
Daratumumab,
Dexamethasone		5件: D00287 ,
D00292 (Name: Dexamethasone),
D03150 ,
D07760 ,
D10777 		3件: CD38,
NR3C1,
PSMB5 💬		16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬1件: 28
10Dexamethason----4件: 13, 28, 46, 331
11Dexamethasone1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299
12Dexamethasone (1 cycle)1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63
13Dexamethasone (4 cycles)1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63
14Dexamethasone (50mg 1dd6, 3 consecutive days/month)1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 35
15Dexamethasone (or equivalent)1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 257
16Dexamethasone 0,1 mg Tablets1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
17Dexamethasone 0,5mg1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84
18Dexamethasone 0.5mg Tablet1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
19Dexamethasone 0.5mg/5ml solution1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162
20Dexamethasone 0.5mg/5ml solution in Mucolox™1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 35, 162
21Dexamethasone 1,5 mg Tablets1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
22Dexamethasone 21-dihydrogen phosphate3件: Dexamethasone,
Hydrogen,
Phosphate ion		1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65
23Dexamethasone 21-phosphate2件: Dexamethasone,
Phosphate ion		1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97
24Dexamethasone 2mg Tablets1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
25Dexamethasone 4 mg JENAPHARM1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28
26Dexamethasone Abcur1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63
27Dexamethasone and Rituximab2件: Dexamethasone,
Rituximab		2件: D00292 (Name: Dexamethasone),
D02994 		2件: MS4A1,
NR3C1 💬		2件: Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬1件: 63
28Dexamethasone given orally1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13
29Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland).1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 235
30Dexamethasone Oral, 10 mg1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28
31Dexamethasone Oral, 20 mg1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28
32Dexamethasone Parotid Irrigation1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 53
33DEXAMETHASONE SODIUM PHOSPHATE2件: Dexamethasone,
Phosphate ion		1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 65, 70, 96
34Dexamethasone sodium phosphate (soluzione 25mg/ml)2件: Dexamethasone,
Phosphate ion		1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65
35Dexamethasone sodium phosphate 250 mg/ 10 ml2件: Dexamethasone,
Phosphate ion		1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96
36Dexamethasone sodium phosphate 250 mg/10 ml solution2件: Dexamethasone,
Phosphate ion		1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 299
37DEXAMETHASONE SODIUM PHOSPHATE PH. EUR.2件: Dexamethasone,
Phosphate ion		1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65
38DEXAMETHASONE SODIUM SULFATE3件: Dexamethasone,
Sodium sulfate,
Sulfate ion		2件: D00292 (Name: Dexamethasone),
D05877 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28
39Dexamethasone soduim phosphate2件: Dexamethasone,
Phosphate ion		1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13
40Dexamethasone, 40 mg1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 28
41Dexamethasone, procarbazine2件: Dexamethasone,
Procarbazine		2件: D00292 (Name: Dexamethasone),
D08423 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65
42High dose Dexamethasone pulses1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63
43Intraarticular dexamethasone1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
44Intravenous Dexamethasone 1 mg1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
45Lenalidomide and dexamethasone2件: Dexamethasone,
Lenalidomide		2件: D00292 (Name: Dexamethasone),
D04687 		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16
46Lenalidomide+Dexamethasone2件: Dexamethasone,
Lenalidomide		2件: D00292 (Name: Dexamethasone),
D04687 		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16
47Lenalidomide, Dexamethasone2件: Dexamethasone,
Lenalidomide		2件: D00292 (Name: Dexamethasone),
D04687 		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 16
48Lenalidomide, Dexamethasone and Cyclophosphamide3件: Cyclophosphamide,
Dexamethasone,
Lenalidomide		4件: D00287 ,
D00292 (Name: Dexamethasone),
D04687 ,
D07760 		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28
49Melphalan, thalidomide and dexamethasone3件: Dexamethasone,
Melphalan,
Thalidomide		3件: D00292 (Name: Dexamethasone),
D00369 ,
D00754 		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28
50MMF and Dexamethasone1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222
51Peri-neural Dexamethasone 1 mg1件: Dexamethasone1件: D00292 (Name: Dexamethasone)1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
52Pomalidomide and Dexamethasone2件: Dexamethasone,
Pomalidomide		2件: D00292 (Name: Dexamethasone),
D08976 		3件: IL6,
NR3C1,
TNF 💬		81件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28
53Romiplostim plus dexamethasone2件: Dexamethasone,
Romiplostim		2件: D00292 (Name: Dexamethasone),
D08990 		2件: MPL,
NR3C1 💬		3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 63
54SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)3件: Bortezomib,
Cyclophosphamide,
Dexamethasone		4件: D00287 ,
D00292 (Name: Dexamethasone),
D03150 ,
D07760 		2件: NR3C1,
PSMB5 💬		9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28
55Venetoclax MTD with Dexamethasone2件: Dexamethasone,
Venetoclax		2件: D00292 (Name: Dexamethasone),
D10679 		2件: BCL2,
NR3C1 💬		44件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬1件: 28